280 related articles for article (PubMed ID: 12131317)
1. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW
J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317
[TBL] [Abstract][Full Text] [Related]
2. Body size and prostate cancer: a population-based case-control study in China.
Hsing AW; Deng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Benichou J; Xie T; Gao YT
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1335-41. PubMed ID: 11142419
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factors and risk of benign prostatic hyperplasia.
Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Prostate; 2002 Jul; 52(2):98-105. PubMed ID: 12111701
[TBL] [Abstract][Full Text] [Related]
4. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
[TBL] [Abstract][Full Text] [Related]
5. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
6. History of weight and obesity through life and risk of benign prostatic hyperplasia.
Zucchetto A; Tavani A; Dal Maso L; Gallus S; Negri E; Talamini R; Franceschi S; Montella M; La Vecchia C
Int J Obes (Lond); 2005 Jul; 29(7):798-803. PubMed ID: 15917855
[TBL] [Abstract][Full Text] [Related]
7. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
8. Birth weight, abdominal obesity and the risk of lower urinary tract symptoms in a population based study of Swedish men.
Laven BA; Orsini N; Andersson SO; Johansson JE; Gerber GS; Wolk A
J Urol; 2008 May; 179(5):1891-5; discussion 1895-6. PubMed ID: 18353377
[TBL] [Abstract][Full Text] [Related]
9. Abdominal obesity is associated with increased risk of acute coronary events in men.
Lakka HM; Lakka TA; Tuomilehto J; Salonen JT
Eur Heart J; 2002 May; 23(9):706-13. PubMed ID: 11977996
[TBL] [Abstract][Full Text] [Related]
10. Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia.
Mendoza-Núñez VM; García-Sánchez A; Sánchez-Rodríguez M; Galván-Duarte RE; Fonseca-Yerena ME
Obes Res; 2002 Apr; 10(4):253-9. PubMed ID: 11943833
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
Vaughan TL; Kristal AR; Blount PL; Levine DS; Galipeau PC; Prevo LJ; Sanchez CA; Rabinovitch PS; Reid BJ
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):745-52. PubMed ID: 12163328
[TBL] [Abstract][Full Text] [Related]
12. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
13. Anthropometric predictors of serum fasting insulin in 9- and 15-year-old children and adolescents.
Thorsdottir I; Gunnarsdottir I; Palsson GI; Johannsson E
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):263-71. PubMed ID: 16679218
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.
Gupta R; Sarna M; Thanvi J; Rastogi P; Kaul V; Gupta VP
Indian Heart J; 2004; 56(6):646-52. PubMed ID: 15751521
[TBL] [Abstract][Full Text] [Related]
15. Re: Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
Rohrmann S; Platz EA; Smit E; Giovannucci E
J Urol; 2004 Aug; 172(2):779. PubMed ID: 15247791
[No Abstract] [Full Text] [Related]
16. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid.
Lin JD; Chiou WK; Chang HY; Liu FH; Weng HF
Metabolism; 2007 Jun; 56(6):751-6. PubMed ID: 17512306
[TBL] [Abstract][Full Text] [Related]
17. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.
Stattin P; Palmqvist R; Söderberg S; Biessy C; Ardnor B; Hallmans G; Kaaks R; Olsson T
Oncol Rep; 2003; 10(6):2015-21. PubMed ID: 14534736
[TBL] [Abstract][Full Text] [Related]
18. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.
Ruhl CE; Everhart JE
Gastroenterology; 2003 Jan; 124(1):71-9. PubMed ID: 12512031
[TBL] [Abstract][Full Text] [Related]
19. Relationship of leptin concentration to gender, body mass index and age in Saudi adults.
Al-Harithy RN
Saudi Med J; 2004 Aug; 25(8):1086-90. PubMed ID: 15322603
[TBL] [Abstract][Full Text] [Related]
20. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women.
Xu WH; Matthews CE; Xiang YB; Zheng W; Ruan ZX; Cheng JR; Gao YT; Shu XO
Am J Epidemiol; 2005 May; 161(10):939-47. PubMed ID: 15870158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
